Pharma & Biopharma

The 2024 Power List tell us about important problems that could – and should – be tackled through interdisciplinary work

Study provides a framework for controlling molecular reactions at the atomic scale – with potential implications for nanotechnology and pharma

The countdown begins! We reveal the first five innovations to make this year’s Innovation Awards.

We asked The 2024 Power List: what’s missing from the analytical toolbox?

Stefan Foser, VP of Global Pharma at Bruker, reflects on the importance of analytical technology in the “post-genomic era”

Advancements in sample preparation, coupling separations, and data collection are paving the way for broader CD-MS adoption

Why Evan Williams is surprised that more companies aren’t interested in commercializing charge-detection technologies

Where is the success of the mRNA vaccines during the COVID-19 pandemic taking the field of nucleotide-based therapies?

How handheld Raman spectroscopy instruments are making a mark in raw materials identification

NMR reveals how different siRNA mixing methods affect lipid nanoparticles’ internal structure and gene-silencing efficiency